ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NHS National Framework Agreement for Omalizumab

NHS England · Preliminary market engagement notice on Find a Tender

Tender information last checkedLast checked 30 Sept 2026, 08:00.

Opportunity overview

Project title: NHS National Framework for Omalizumab commencing 1st February 2026 Offer reference number: CM/TNS/25/5734 Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

CELLTRION HEALTHCARE UNITED KINGDOM LIMITED

Matched by number
Shared published award value
£87.4m
Awarded
26 Nov 2025
Suppliers
One of 3 awarded suppliers
Award ID
1
Status
pending
Identifier
GB-COH 11685363
Location
Uxbridge, UKI74, UB8 1JG, United Kingdom

MERCURY PHARMACEUTICALS LIMITED

Matched by number
Shared published award value
£87.4m
Awarded
26 Nov 2025
Suppliers
One of 3 awarded suppliers
Award ID
1
Status
pending
Identifier
GB-COH 02619880
Location
London, UKI31, EC2M 1QS, United Kingdom

NOVARTIS PHARMACEUTICALS UK LIMITED

Matched by number
Shared published award value
£87.4m
Awarded
26 Nov 2025
Suppliers
One of 3 awarded suppliers
Award ID
1
Status
pending
Identifier
GB-COH 00119006
Location
London, UKI33, W12 7FQ, United Kingdom

Celltrion Healthcare United Kingdom Limited

Matched by number
Shared contract value
£87.4m
Awarded
Not supplied
Contract signed
12 Dec 2025
Including VAT
£104.9m
Suppliers
One of 3 awarded suppliers
Award ID
2
Status
active
Identifier
GB-COH 11685363
Location
Uxbridge, UKI74, UB8 1JG, United Kingdom

MERCURY PHARMACEUTICALS LIMITED

Matched by number
Shared contract value
£87.4m
Awarded
Not supplied
Contract signed
12 Dec 2025
Including VAT
£104.9m
Suppliers
One of 3 awarded suppliers
Award ID
2
Status
active
Identifier
GB-COH 02619880
Location
London, UKI31, EC2M 1QS, United Kingdom

NOVARTIS PHARMACEUTICALS UK LIMITED

Matched by number
Shared contract value
£87.4m
Awarded
Not supplied
Contract signed
12 Dec 2025
Including VAT
£104.9m
Suppliers
One of 3 awarded suppliers
Award ID
2
Status
active
Identifier
GB-COH 00119006
Location
London, UKI33, W12 7FQ, United Kingdom

Classification

  • CPV33600000 — Pharmaceutical products

Lots

  • Lot 1£85.8m

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
C382504
Status
complete
Above Threshold
Yes
Procurement Method
open
Main Procurement Category
goods
How to submit
The procurement documents are available for unrestricted and full direct access, free of charge at https://health-family.force.com/s/Welcome Additional info obtained from the abovementioned address Tenders must be submitted to the abovementioned address
Procurement Method Details
Open procedure

Covered By

GPA

Legal basis

Id
2023/54
Scheme
UKPGA

Techniques

Has Framework Agreement
Yes

Framework Agreement

Type
closed
Method
withReopeningCompetition
Description
Please refer to the ITO Documents for the Operation Description
Buyer Categories
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points.

Expected award period

Ends
26 Nov 2025, 23:59

Tender Period

Ends
30 Oct 2025, 13:00

Communication

Future Notice Date
1 Oct 2025, 23:59

Enquiry period

Ends
23 Oct 2025, 13:00

Submission terms

Electronic Submission Policy
allowed

Languages

en

Lots and requirements

Entry 1
Id
1
Status
complete
Has Renewal
Yes

Value

Amount
85,785,000
Currency
GBP
Including VAT
102,942,000

Renewal

Description
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Suitability

Sme
Yes

Award criteria

Criteria

Criterion 1
Name
Price is not the only award criterion
Type
price
Description
Price is not the only award criterion

Numbers

Entry 1
Number
100
Weight
percentageExact

Contract period

Ends
31 Aug 2027, 23:59
Starts
1 Feb 2026, 00:00
Max Extent Date
31 Aug 2029, 23:59

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKC
Country
GB
Country Name
United Kingdom
Entry 2
Region
UKD
Country
GB
Country Name
United Kingdom
Entry 3
Region
UKF
Country
GB
Country Name
United Kingdom
Entry 4
Region
UKG
Country
GB
Country Name
United Kingdom
Entry 5
Region
UKH
Country
GB
Country Name
United Kingdom
Entry 6
Region
UKJ
Country
GB
Country Name
United Kingdom
Entry 7
Region
UKK
Country
GB
Country Name
United Kingdom
Entry 8
Region
UKC
Country
GB
Country Name
United Kingdom
Entry 9
Region
UKD
Country
GB
Country Name
United Kingdom
Entry 10
Region
UKF
Country
GB
Country Name
United Kingdom
Entry 11
Region
UKG
Country
GB
Country Name
United Kingdom
Entry 12
Region
UKH
Country
GB
Country Name
United Kingdom
Entry 13
Region
UKJ
Country
GB
Country Name
United Kingdom
Entry 14
Region
UKK
Country
GB
Country Name
United Kingdom

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Published documents

Entry 1
Id
conflictOfInterest
Description
Not published
Document Type
conflictOfInterest
Entry 2
Id
A-5812
Format
application/vnd.openxmlformats-officedocument.wordprocessingml.document
Document Type
biddingDocuments
Entry 3
Id
A-5813
Format
application/vnd.openxmlformats-officedocument.wordprocessingml.document
Document Type
biddingDocuments
Entry 4
Id
A-5814
Format
application/vnd.openxmlformats-officedocument.wordprocessingml.document
Document Type
biddingDocuments
Entry 5
Id
A-5815
Format
application/vnd.openxmlformats-officedocument.wordprocessingml.document
Document Type
biddingDocuments
Entry 6
Id
A-5816
Format
application/vnd.openxmlformats-officedocument.wordprocessingml.document
Document Type
biddingDocuments
Entry 7
Id
A-5817
Format
application/xml
Document Type
biddingDocuments
Entry 8
Id
A-5818
Format
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Document Type
biddingDocuments
Entry 9
Id
A-5819
Format
application/vnd.openxmlformats-officedocument.wordprocessingml.document
Document Type
biddingDocuments
Entry 10
Id
A-5820
Format
application/msword
Document Type
biddingDocuments
Entry 11
Id
A-5821
Format
application/vnd.ms-excel
Document Type
biddingDocuments
Entry 12
Id
A-5822
Format
application/vnd.ms-excel
Document Type
biddingDocuments
Entry 13
Id
A-5823
Format
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Document Type
biddingDocuments
Entry 14
Id
061970-2025
Format
text/html
Notice Type
UK4
Description
Tender notice on Find a Tender
Document Type
tenderNotice
Published
3 Oct 2025, 08:53

Planning and budget

Documents

Entry 1
Id
051371-2025
Format
text/html
Notice Type
UK2
Description
Preliminary market engagement notice on Find a Tender
Document Type
marketEngagementNotice
Published
26 Aug 2025, 17:01

Milestones

Entry 1
Id
engagement
Type
engagement
Status
scheduled
Due
18 Sept 2025, 23:59
Description
NHS England is seeking to engage with suppliers that are planning to launch Omalizumab injection. Interested suppliers will be invited to a virtual PME meeting to be held on Thursday 18th September 2025 The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.

Buyer, suppliers and contacts

Organisation 1
Id
GB-PPON-PDPT-3135-BWWY
Name
NHS England

Roles

buyer

Address

Region
UKI45
Country
GB
Locality
London
Postal Code
SE1 8UG
Country Name
United Kingdom
Street Address
Wellington House, 133-135 Waterloo Rd

Details

Classifications

Entry 1
Id
publicAuthorityCentralGovernment
Scheme
UK_CA_TYPE
Description
Public authority - central government

Identifier

Id
PDPT-3135-BWWY
Scheme
GB-PPON

Contact

Name
Katie Noonan
Organisation 2
Id
GB-COH-11685363
Name
Celltrion Healthcare United Kingdom Limited

Roles

supplier

Address

Region
UKI74
Country
GB
Locality
Uxbridge
Postal Code
UB8 1JG
Country Name
United Kingdom
Street Address
The Charter Building

Control

Description
n/a

Details

Vcse
No
Scale
large
Sheltered Workshop
No
Public Service Mission Organization
No

Identifier

Id
11685363
Scheme
GB-COH

Contact

Organisation 3
Id
GB-COH-02619880
Name
MERCURY PHARMACEUTICALS LIMITED

Roles

supplier

Address

Region
UKI31
Country
GB
Locality
London
Postal Code
EC2M 1QS
Country Name
United Kingdom
Street Address
Dashwood House

Control

Description
n/a

Details

Vcse
No
Scale
large
Sheltered Workshop
No
Public Service Mission Organization
No

Identifier

Id
02619880
Scheme
GB-COH

Contact

Organisation 4
Id
GB-COH-00119006
Name
NOVARTIS PHARMACEUTICALS UK LIMITED

Roles

supplier

Address

Region
UKI33
Country
GB
Locality
London
Postal Code
W12 7FQ
Country Name
United Kingdom
Street Address
2nd Floor, The Westworks Building White City Place

Control

Description
n/a

Details

Vcse
No
Scale
large
Sheltered Workshop
No
Public Service Mission Organization
No

Identifier

Id
00119006
Scheme
GB-COH

Contact

Award information

Award 1
Id
1
Date
26 Nov 2025, 00:00
Title
Lot 1 - CM/TNS/25/5734
Status
pending
Has Renewal
Yes
Above Threshold
Yes
Main Procurement Category
goods
Assessment Summaries Date Sent
28 Nov 2025, 00:00

Items

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKC
Country
GB
Country Name
United Kingdom
Entry 2
Region
UKD
Country
GB
Country Name
United Kingdom
Entry 3
Region
UKF
Country
GB
Country Name
United Kingdom
Entry 4
Region
UKG
Country
GB
Country Name
United Kingdom
Entry 5
Region
UKH
Country
GB
Country Name
United Kingdom
Entry 6
Region
UKJ
Country
GB
Country Name
United Kingdom
Entry 7
Region
UKK
Country
GB
Country Name
United Kingdom

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Value

Amount
87,433,000
Currency
GBP
Including VAT
104,919,600

Renewal

Description
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Documents

Entry 1
Id
078054-2025
Format
text/html
Notice Type
UK6
Description
Contract award notice on Find a Tender
Document Type
awardNotice
Published
28 Nov 2025, 12:23

Suppliers

Supplier 1
Id
GB-COH-11685363
Name
CELLTRION HEALTHCARE UNITED KINGDOM LIMITED
Supplier 2
Id
GB-COH-02619880
Name
MERCURY PHARMACEUTICALS LIMITED
Supplier 3
Id
GB-COH-00119006
Name
NOVARTIS PHARMACEUTICALS UK LIMITED

Milestones

Entry 1
Id
1
Type
futureSignatureDate
Status
scheduled
Due
23 Dec 2025, 23:59

Related lots

1

Contract period

Ends
31 Aug 2027, 23:59
Starts
1 Feb 2026, 00:00
Max Extent Date
31 Aug 2029, 23:59

Subcontracting

Subcontracts

Entry 1
Id
1
Description
n/a

Main Contractors

Entry 1
Id
GB-COH-11685363
Name
NOVARTIS PHARMACEUTICALS UK LIMITED
Entry 2
Id
2
Description
n/a

Main Contractors

Entry 1
Id
GB-COH-02619880
Entry 3
Id
3
Description
n/a

Main Contractors

Entry 1
Id
GB-COH-00119006

Standstill Period

Ends
10 Dec 2025, 23:59
Award 2
Id
2
Status
active
Main Procurement Category
goods

Items

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKC
Country
GB
Country Name
United Kingdom
Entry 2
Region
UKD
Country
GB
Country Name
United Kingdom
Entry 3
Region
UKF
Country
GB
Country Name
United Kingdom
Entry 4
Region
UKG
Country
GB
Country Name
United Kingdom
Entry 5
Region
UKH
Country
GB
Country Name
United Kingdom
Entry 6
Region
UKJ
Country
GB
Country Name
United Kingdom
Entry 7
Region
UKK
Country
GB
Country Name
United Kingdom

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Suppliers

Supplier 1
Id
GB-COH-11685363
Name
Celltrion Healthcare United Kingdom Limited
Supplier 2
Id
GB-COH-02619880
Name
MERCURY PHARMACEUTICALS LIMITED
Supplier 3
Id
GB-COH-00119006
Name
NOVARTIS PHARMACEUTICALS UK LIMITED

Related lots

1

Contracts and changes

Entry 1
Id
2
Title
Lot 1 - CM/TNS/25/5734
Status
active
Award ID
2
Date Signed
12 Dec 2025, 00:00
Has Renewal
Yes
Above Threshold
Yes

Value

Amount
87,433,000
Currency
GBP
Including VAT
104,919,600

Period

Ends
31 Aug 2027, 23:59
Starts
1 Feb 2026, 00:00
Max Extent Date
31 Aug 2029, 23:59

Renewal

Description
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Documents

Entry 1
Id
A-9646
Format
application/pdf
Description
CONTRACT COPY Documents UK7 Contract Details Notice - CM-TNS-25-5734 Omalizumab
Document Type
contractSigned
Entry 2
Id
086501-2025
Format
text/html
Notice Type
UK7
Description
Contract details notice on Find a Tender
Document Type
contractNotice
Published
30 Dec 2025, 16:29

Recorded locations

  • Buyer location · London · UKI45 · SE1 8UG · United Kingdom
  • Delivery location · UKC · United Kingdom
  • Delivery location · UKD · United Kingdom
  • Delivery location · UKF · United Kingdom
  • Delivery location · UKG · United Kingdom
  • Delivery location · UKH · United Kingdom
  • Delivery location · UKJ · United Kingdom
  • Delivery location · UKK · United Kingdom

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-058e04-2025-12-30T16:29:54ZPreliminary market engagement notice on Find a Tender ·